The glucose clamp reveals an association between adiponectin gene polymorphisms and insulin sensitivity in obese subjects

International Journal of Obesity

Volumn 31, Issue 3, 2007, Pages 424-428

  Buzzetti, R ^a   Petrone, A ^a   Zavarella, S ^a   Zampetti, S ^a   Spoletini, M ^a   Potenziani, S ^a   Leto, G ^a   Osborn, J ^a   Leonetti, F ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Adiponectin gene; HOMA IR index; Hyperinsulinemic euglycemic clamp; Insulin resistance; SNPs

Indexed keywords

ADIPONECTIN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BODY FAT; COMORBIDITY; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENOTYPE; GLUCOSE CLAMP TECHNIQUE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HYPERINSULINEMIA; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MODEL; OBESITY; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPONECTIN; ADULT; ALLELES; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; LINKAGE DISEQUILIBRIUM; MALE; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33847336953     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0803419     Document Type: Article

References (22)

1. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000; 11: 327-332.
2. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schulthess T et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J Biol Chem 2003; 278: 9073-9085.
3. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003; 423: 762-769.
4. Menzaghi C, Ercolino T, Di Paola R, Berg AH, Warram JH, Scherer PE et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 2002; 51: 2306-2312.
5. Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002; 51: 536-540.
6. Stumvoll M, Tschritter O, Fritsche A, Staiger H, Renn W, Weisser M et al. Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes 2002; 51: 37-41.
7. Hu FB, Doria A, Li T, Meigs JB, Liu S, Memisoglu A et al. Genetic variation at the adiponectin locus and risk of type 2 diabetes in women. Diabetes 2004; 53: 209-213.
8. Gu HF, Abulaiti A, Ostenson CG, Humphreys K, Wahlestedt C, Brookes AJ et al. Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish caucasians. Diabetes 2004; 53: S31-S35.
9. Vozarova de Courten B, Hanson RL, Funahashi T, Lindsay RS, Matsuzawa Y, Tanaka S et al. Common Polymorphisms in the Adiponectin Gene ACDC Are Not Associated With Diabetes in Pima Indians. Diabetes 2005; 54: 284-289.
10. Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, Gaget S et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 2002; 21: 2607-2614.
11. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-E223.
12. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci VC, Leonetti F. Prevalence of uncomplicated obesity in an Italian obese population. Obes Res 2005; 13: 1116-1122.
13. Natali A, Toschi E, Camastra S, Gastaldelli A, Groop L, Ferrannini E. Determinants of postabsorptive endogenous glucose output in non-diabetic subjects. European Group for the Study of Insulin Resistance (EGIR). Diabetologia 2000; 43: 1266-1272.
14. Lukasky HC, Johnson PE, Bolonchuk WW, Lykken GI. Assessment of fat free mass using bioelectrical impedance measurements of human body. Am J Clin Nutr 1985; 41: 810-817.
15. Friedewald WT, Levy RJ, Fredrickson DS. Estimation of the concentration of low-density-lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
16. Gorden P, Lesniak MA, Hendricks CM, Roth J. 'Big' growth hormone components from human plasma: decreased reactivity demonstrated by radioreceptor assay. Science 1973; 182: 829-831.
17. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001; 7: 947-953.
18. Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004; 68: 975-981.
19. Schaffler A, Langmann T, Palitzsch KD, Scholmerich J, Schmitz G. Identification and characterization of the human adipocyte apM-1 promoter. Biochim Biophys Acta 1998; 20: 187-197.
20. Lihn AS, Pedersen SB, Richelsen B. Adiponectin action, regulation and association to insulin sensitivity. Obes Rev 2005; 6: 13-21.
21. Bouatia-Naji N, Meyre D, Lobbens S, Seron K, Fumeron F, Balkau B et al. ACDC/adiponectin polymorphisms are associated with severe childhood and adult obesity. Diabetes 2006; 55: 545-550.
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.